Foresite Capital Management V, LLC
Source: SEC Form 13F · as of Mar 2026Foresite Capital Management V, LLC holds 6 biotech & pharma companies tracked by BioSniper, totaling $173.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$173.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALUMIS INC. (ALMS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALMSALUMIS INC. | 5,896,995 | $129.9M |
| IRONDisc Medicine, Inc. | 374,069 | $23.9M |
| LYELLyell Immunopharma, Inc. | 477,078 | $9.6M |
| PHVSPharvaris N.V. | 194,125 | $5.5M |
| NRIXNurix Therapeutics, Inc. | 265,000 | $4.1M |
| MAZEMaze Therapeutics, Inc. | 25,905 | $773K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.